Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers - PubMed (original) (raw)
Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers
Z M Zheng et al. J Virol. 1997 Dec.
Abstract
Alternative splicing plays an important role in regulation of bovine papillomavirus type 1 (BPV-1) gene expression. We have recently identified in BPV-1 late pre-mRNAs two purine-rich exonic splicing enhancers (SE1 and SE2) which also stimulate splicing of a Drosophila doublesex (dsx) pre-mRNA containing a suboptimal 3' splice site. In vivo studies now demonstrate that both SE1 and SE2 are required for preferential use of the BPV-1 nucleotide (nt) 3225 3' splice site in nonpermissive cells. Deletion or mutation of either element in a BPV-1 late pre-mRNA switches splicing to the late-specific alternative 3' splice site at nt 3605. To investigate the sequence specificity of these exonic splicing enhancers, various mutant SE1 or SE2 elements were connected to dsx pre-mRNAs and tested for their stimulatory effects on dsx pre-mRNA splicing in vitro. Substitution of U residues for either A or G residues in and around potential ASF/SF2 binding sites in SE1 or SE2 resulted in a significant reduction of splicing enhancer activity. However, the G-to-U substitutions in both enhancers had the largest effect, reducing splicing to near control levels. Further in vitro analyses showed that splicing enhancement by SE2 could be competed with excess unlabeled SE2 RNA, indicating that SE2 activity in HeLa nuclear extracts is mediated by trans-acting factors. UV cross-linking plus immunoprecipitation assays showed that both wild-type SE1 and SE2 RNAs could bind directly to purified HeLa SR proteins SRp30a (ASF/SF2), SRp55, and SRp75. UV cross-linking experiments also identified a 23-kDa protein which binds to SE2 but not SE1. This protein is present in both HeLa nuclear extracts and S100 extracts but absent from SR protein preparations, suggesting that it is not a classical SR protein. Mutant SE elements (containing G- to U-mutations) which had minimal splicing enhancer activity also had very weak binding capacity for these proteins, strongly suggesting that the binding of these proteins is required for splicing enhancer function.
Similar articles
- Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.
Zheng ZM, Quintero J, Reid ES, Gocke C, Baker CC. Zheng ZM, et al. J Virol. 2000 Jul;74(13):5902-10. doi: 10.1128/jvi.74.13.5902-5910.2000. J Virol. 2000. PMID: 10846071 Free PMC article. - Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site.
Zheng ZM, He PJ, Baker CC. Zheng ZM, et al. J Virol. 1999 Jan;73(1):29-36. doi: 10.1128/JVI.73.1.29-36.1999. J Virol. 1999. PMID: 9847303 Free PMC article. - Regulation of bovine papillomavirus type 1 gene expression by RNA processing.
Jia R, Zheng ZM. Jia R, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(4):1270-82. doi: 10.2741/3307. Front Biosci (Landmark Ed). 2009. PMID: 19273129 Free PMC article. Review. - Can the HIV-1 splicing machinery be targeted for drug discovery?
Dlamini Z, Hull R. Dlamini Z, et al. HIV AIDS (Auckl). 2017 Mar 10;9:63-75. doi: 10.2147/HIV.S120576. eCollection 2017. HIV AIDS (Auckl). 2017. PMID: 28331370 Free PMC article. Review.
Cited by
- HPV and RNA Binding Proteins: What We Know and What Remains to Be Discovered.
Graham SV. Graham SV. Viruses. 2024 May 15;16(5):783. doi: 10.3390/v16050783. Viruses. 2024. PMID: 38793664 Free PMC article. Review. - HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation.
Yu L, Majerciak V, Zheng ZM. Yu L, et al. Int J Mol Sci. 2022 Apr 29;23(9):4943. doi: 10.3390/ijms23094943. Int J Mol Sci. 2022. PMID: 35563334 Free PMC article. Review. - The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.
Alvelos MI, Brüggemann M, Sutandy FR, Juan-Mateu J, Colli ML, Busch A, Lopes M, Castela Â, Aartsma-Rus A, König J, Zarnack K, Eizirik DL. Alvelos MI, et al. Life Sci Alliance. 2020 Dec 29;4(3):e202000825. doi: 10.26508/lsa.202000825. Print 2021 Mar. Life Sci Alliance. 2020. PMID: 33376132 Free PMC article. - Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y, Jönsson J, Hao C, Shoja Chaghervand S, Cui X, Kajitani N, Gong L, Wu C, Schwartz S. Zheng Y, et al. J Virol. 2020 Sep 29;94(20):e01509-20. doi: 10.1128/JVI.01509-20. Print 2020 Sep 29. J Virol. 2020. PMID: 32759322 Free PMC article. - Progress Toward Development of Effective and Safe African Swine Fever Virus Vaccines.
Sang H, Miller G, Lokhandwala S, Sangewar N, Waghela SD, Bishop RP, Mwangi W. Sang H, et al. Front Vet Sci. 2020 Feb 21;7:84. doi: 10.3389/fvets.2020.00084. eCollection 2020. Front Vet Sci. 2020. PMID: 32154279 Free PMC article. Review.
References
- Mol Cell Biol. 1994 Feb;14(2):1347-54 - PubMed
- Science. 1996 Sep 20;273(5282):1706-9 - PubMed
- Nucleic Acids Res. 1994 May 11;22(9):1515-26 - PubMed
- Nature. 1994 Jun 23;369(6482):678-82 - PubMed
- Cell. 1994 Jun 17;77(6):805-15 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials